The preservation of living cells and tissues is an often-underappreciated obstacle in the clinical lab. Cryogenic temperatures attempt to address this challenge by minimizing biochemical activity within samples of interest. As the cell and gene therapy market grows, the drawbacks of cryopreservation are becoming more apparent.
This article examines the current cryopreservation landscape within the cell and gene therapy market and explores emerging solutions to meeting supply demands and patient safety standards
